PDA数据完整性行为守则要素中英对照版
Pare
teralDrugAssociatio
Poi
tstoCo
sider注射剂协会考虑要点Eleme
tsofaCodeofCo
ductforDataI
tegrity数据完整性行为守则要素I
troductio
简介DataI
tegrityhasbee
a
dcurre
tlyisamajorglobalco
cer
ofHealthAuthoritiesa
dthepharmaceuticali
dustryAlthough
ota
ewissue
umerousrece
tHealthAuthoritye
forceme
tactio
ssuchasWar
i
gLettersImportAlertsProductDete
tio
sa
dsuspe
sio
orrevocatio
ofMarketi
gAuthorizatio
shasfocusedatte
tio
o
DataI
tegrityDataI
tegrityca
resultfromlackofaware
essofregulatoryrequireme
tsemployeeerrorsfailuretocheckaccuracyofdatasoftwareorsystemmalfu
ctio
orco
figuratio
problemswithelectro
icdataha
dli
gormalfeasa
cebyemployeesToholisticallyaddressDataI
tegritythePare
teralDrugAssociatio
PDAisdevelopi
gasetoftoolsi
theformofPDATech
icalReportsPDATrai
i
gProgramDataI
tegrityWorkshopsa
dPoi
tstoCo
siderdocume
tsthatca
beusedbyi
dustrytoaddressthisseriousissueThisdocume
tprese
tstheviewsofthePare
teralDrugAssociatio
PDAo
thebe
efitsforcompa
iestovolu
tarilyadoptaCodeofCo
ductforassuri
gdatai
tegrity数据完整性目前已经成为全球卫生机构与制药行业所关注的重点。尽管不是一个新的问题，近期在很多卫生当局的执法行动例如警告信、进口警报、产品扣留，以及暂时取消或撤销上市许可中都非常关注数据完整性的问题。数据完整性可能由于缺乏法规要求意识、员工错误、无法核实数据准确性，软件或系统故障，或电子数据处理配置问题，或员工渎职行为导致。为了全面解决数据完整性问题，注射剂协会PDA正在开发一套面向行业的涵盖PDA技术报告、PDA培训程序、数据完整性研讨会，以及考虑要点文件的工具来解决这一严重问题。本文件代表注射剂协会PDA的观点，公司可自愿采用行为守则来确保数据完整性。HowtoUsethisDocume
t如何使用本文件
Thisdocume
twasdevelopedbyateamwithexpertisei
thefieldsofqualityregulatoryaffairsauditi
ga
dma
ufacturi
ga
dreviewedbyattor
eysspecializedi
fooddruga
dlaborlawThisdocume
tiswritte
foreasyadoptio
i
partori
itse
tiretybycompa
iesiftheysochoosewithoutthe
eedforexte
siverewriti
gofthedocume
tThereforetheterms‘shall’a
d‘must’havebee
usedtopermittheCodetobee
forceablebyacompa
yifadoptedThisdocume
tisi
te
dedtorei
forceaculture
fofqualitya
dtrustwithi
thepharmaceuticali
dustryItis
oti
te
dedtobearegulatorysta
dardorguida
ce
orisiti
te
dedtosupersedea
ycou
tryspecificorlocallawsa
dregulatio
sgover
i
glaborprivacya
doremployeerights本文档由在质量、药政事务、审计及制r